SRPT

Sarepta Therapeutics, Inc. is a pioneering biopharmaceutical company based in Cambridge, Massachusetts, that focuses on the development of RNA-targeted and gene therapies for rare genetic disorders, particularly Duchenne muscular dystrophy (DMD). With an innovative pipeline and a strong commitment to addressing significant unmet medical needs, Sarepta is reshaping treatment paradigms in genetic medicine. The company's advanced scientific expertise and cutting-edge technologies position it as a leader in the biopharmaceutical sector, driving transformative therapies that have the potential to significantly improve patient outcomes.